[HTML][HTML] Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose …
J Jacob, T Biering-Sørensen, L Holger Ehlers… - Vaccines, 2023 - mdpi.com
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines …
J Jacob, T Biering-Sørensen, LH Ehlers… - Vaccines, 2023 - search.proquest.com
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in …
J Jacob, T Biering-Sørensen, L Holger Ehlers… - Vaccines, 2023 - search.ebscohost.com
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59< sup>® …
influenza compared with any other age group. Enhanced vaccines, as the MF59< sup>® …
Cost-effectiveness of vaccination of older adults with an MF59®-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in …
J Jacob, T Biering-Sørensen, LH Ehlers, CH Edwards… - 2023 - cabidigitallibrary.org
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in …
J Jacob, T Biering-Sørensen, L Holger Ehlers… - 2023 - ntnuopen.ntnu.no
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in …
J Jacob, T Biering-Sørensen, L Holger Ehlers… - 2023 - bora.uib.no
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in …
J Jacob, T Biering-Sørensen, LH Ehlers… - Vaccines, 2023 - research.regionh.dk
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines …
J Jacob, T Biering-Sørensen, H Ehlers, CH Edwards… - Vaccines, 2023 - europepmc.org
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in …
J Jacob, T Biering-Sørensen, LH Ehlers… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
[HTML][HTML] Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose …
J Jacob, T Biering-Sørensen, LH Ehlers, CH Edwards… - Vaccines, 2023 - ncbi.nlm.nih.gov
Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …
influenza compared with any other age group. Enhanced vaccines, as the MF59® …